Glenview Capital Management Buys Fiserv Inc, Global Payments Inc, Myriad Genetics Inc, Sells First Data Corp, FMC Corp, LyondellBasell Industries NV

• New Purchases: FISV, GPN, MYGN, FIS, NWL, AGN, TPR, SSNC, ADT,
• Added Positions: BHC, CAR, HCA, THC, NUAN, CI, DXC, ENDP, TMUS, TAK, UNVR, WCG, WMB,
• Reduced Positions: FMC, LYB, UHS, NXPI, LBTYK, GOOGL, HOLX, MCK, LBTYA, LTHM, HUM, IQV, ABC, DLPH, TMO, CNC, BKD,
• Sold Out: FDC, WP, NVT, MSFT, BAX, JBL,

For the details of Larry Robbins's stock buys and sells, go to https://www.gurufocus.com/guru/larry+robbins/current-portfolio/portfolio

1. Cigna Corp (CI) - 5,131,781 shares, 8.19% of the total portfolio. Shares added by 3.55%
2. HCA Healthcare Inc (HCA) - 5,340,716 shares, 6.77% of the total portfolio. Shares added by 5.80%
3. McKesson Corp (MCK) - 4,004,618 shares, 5.76% of the total portfolio. Shares reduced by 11.12%
4. IQVIA Holdings Inc (IQV) - 3,617,697 shares, 5.69% of the total portfolio. Shares reduced by 6.57%
5. Takeda Pharmaceutical Co Ltd (TAK) - 27,443,846 shares, 4.97% of the total portfolio. Shares added by 3.83%

Glenview Capital Management initiated holding in Fiserv Inc. The purchase prices were between $92.51 and $108.7, with an estimated average price of $102.05. The stock is now traded at around $114.11. The impact to a portfolio due to this purchase was 2.96%. The holding were 2,717,742 shares as of .

Glenview Capital Management initiated holding in Global Payments Inc. The purchase prices were between $153.58 and $174.84, with an estimated average price of $163.24. The stock is now traded at around $177.48. The impact to a portfolio due to this purchase was 1.32%. The holding were 789,881 shares as of .

Glenview Capital Management initiated holding in Myriad Genetics Inc. The purchase prices were between $22.08 and $47.08, with an estimated average price of $29.04. The stock is now traded at around $24.51. The impact to a portfolio due to this purchase was 1.11%. The holding were 3,683,306 shares as of .

Glenview Capital Management initiated holding in Fidelity National Information Services Inc. The purchase prices were between $124.57 and $139.62, with an estimated average price of $132.74. The stock is now traded at around $135.56. The impact to a portfolio due to this purchase was 0.81%. The holding were 583,129 shares as of .

Glenview Capital Management initiated holding in Newell Brands Inc. The purchase prices were between $13.43 and $18.72, with an estimated average price of $16.12. The stock is now traded at around $19.96. The impact to a portfolio due to this purchase was 0.47%. The holding were 2,381,247 shares as of .

Glenview Capital Management initiated holding in Allergan PLC. The purchase prices were between $156.34 and $169.61, with an estimated average price of $162.97. The stock is now traded at around $182.47. The impact to a portfolio due to this purchase was 0.27%. The holding were 154,400 shares as of .

Glenview Capital Management added to a holding in Bausch Health Companies Inc by 42.15%. The purchase prices were between $20.88 and $25.66, with an estimated average price of $22.9. The stock is now traded at around $27.75. The impact to a portfolio due to this purchase was 0.94%. The holding were 13,810,514 shares as of .

Glenview Capital Management added to a holding in Avis Budget Group Inc by 40.64%. The purchase prices were between $24.08 and $36.51, with an estimated average price of $30.63. The stock is now traded at around $30.40. The impact to a portfolio due to this purchase was 0.37%. The holding were 4,325,470 shares as of .

Glenview Capital Management added to a holding in Nuance Communications Inc by 33.89%. The purchase prices were between $13.14 and $15.39, with an estimated average price of $14.37. The stock is now traded at around $16.53. The impact to a portfolio due to this purchase was 0.3%. The holding were 7,902,017 shares as of .

Glenview Capital Management added to a holding in Endo International PLC by 52.51%. The purchase prices were between $2.23 and $4.61, with an estimated average price of $3.23. The stock is now traded at around $4.16. The impact to a portfolio due to this purchase was 0.24%. The holding were 21,050,891 shares as of .

Glenview Capital Management sold out a holding in First Data Corp. The sale prices were between $27.48 and $31.69, with an estimated average price of $28.37.

Glenview Capital Management sold out a holding in Worldpay Inc. The sale prices were between $126.43 and $137.85, with an estimated average price of $131.16.

Glenview Capital Management sold out a holding in nVent Electric PLC. The sale prices were between $19.61 and $25.45, with an estimated average price of $22.49.

Glenview Capital Management sold out a holding in Microsoft Corp. The sale prices were between $132.21 and $141.34, with an estimated average price of $137.52.

Glenview Capital Management sold out a holding in Baxter International Inc. The sale prices were between $81.4 and $89.78, with an estimated average price of $85.35.

Glenview Capital Management sold out a holding in Jabil Inc. The sale prices were between $25.92 and $35.77, with an estimated average price of $30.14.